In normal human and murine livers SerpinB3 is virtually undetectable, but its expression is readily appreciable in a significant percentage of liver biopsies from CLD patients, as well as in hepatocellular carcinoma (HCC)12–18 and hepatoblastomas20. This evidence concerns the gene SERPINB3 and hepatocellular carcinoma.